Sj. Kim et al., UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR IS A NOVEL PROGNOSTIC FACTOR IN BREAST-CANCER, Anticancer research, 17(2B), 1997, pp. 1373-1378
Background: There have been many reports that the u-PA system plays an
important role in cancer invasion and metastasis. The binding of u-PA
to its specific cell-surface receptor, u-PAR, is necessary for the ac
tivation of u-PA system. The aim of this study is to evaluate the role
and the prognostic value of u-PAR in cancer invasion and metastasis.
Patients and Methods: u-PAR expression in 104 breast cancers was inves
tigated immunohistochemically using a monoclonal antibody against u-PA
R Results: u-PAR expression was mainly observed both on cancer cells a
nd stromal cells. Patients with high u-PAR expression in cancer cells
or stromal cells had a high relapse rate compared with patients with l
ow u-PAR expression by the Kaplan-Meier method (p=0.035 and 0.011, res
pectively). In uni- and multivariate analysis u-PAR expression in stro
mal cells was significantly correlated with relapse (p=0.017 and 0.043
, respectively). Conclusions: This study has shown that not only cance
r cells but also stromal cells have an important roles in breast cance
r invasion and metastasis, and that u-PAR expression in cancer cells a
nd stromal cells might be a novel prognostic factor in breast cancer.